aTyr Pharma Statistics

Total Valuation

aTyr Pharma has a market cap or net worth of $113.87 million. The enterprise value is $40.28 million.

Market Cap	113.87M
Enterprise Value	40.28M

Important Dates

The next estimated earnings date is Wednesday, August 7, 2024, after market close.

Earnings Date	Aug 7, 2024
Ex-Dividend Date	n/a

Share Statistics

aTyr Pharma has 69.01 million shares outstanding. The number of shares has increased by 57.72% in one year.

Shares Outstanding	69.01M
Shares Change (YoY)	+57.72%
Shares Change (QoQ)	+11.39%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	n/a

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	193.65
Forward PS	n/a
PB Ratio	1.35
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	68.51
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 6.07, with a Debt / Equity ratio of 0.17.

Current Ratio	6.07
Quick Ratio	5.64
Debt / Equity	0.17
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -56.80% and return on invested capital (ROIC) is -59.61%.

Return on Equity (ROE)	-56.80%
Return on Assets (ROA)	-43.90%
Return on Capital (ROIC)	-59.61%
Revenue Per Employee	$10,500
Profits Per Employee	-$963,018
Employee Count	56
Asset Turnover	0.01
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -29.18% in the last 52 weeks.

Beta (1Y)	n/a
52-Week Price Change	-29.18%
50-Day Moving Average	1.75
200-Day Moving Average	1.59
Relative Strength Index (RSI)	39.06
Average Volume (30 Days)	472,469

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, aTyr Pharma had revenue of $588,000 and -$53.93 million in losses. Loss per share was -$0.90.

Revenue	588,000
Gross Profit	588,000
Operating Income	-58.77M
Pretax Income	-53.93M
Net Income	-53.93M
EBITDA	-51.17M
EBIT	-53.93M
Loss Per Share	-$0.90

Full Income Statement

Balance Sheet

The company has $87.71 million in cash and $14.13 million in debt, giving a net cash position of $73.58 million or $1.07 per share.

Cash & Cash Equivalents	87.71M
Total Debt	14.13M
Net Cash	73.58M
Net Cash Per Share	$1.07
Equity / Book Value	84.47M
Book Value Per Share	1.22
Working Capital	80.94M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$55.01 million and capital expenditures -$2.97 million, giving a free cash flow of -$57.98 million.

Operating Cash Flow	-55.01M
Capital Expenditures	-2.97M
Free Cash Flow	-57.98M
FCF Per Share	-$0.88

Full Cash Flow Statement

Margins

Gross margin is 100.00%, with operating and profit margins of -9,994.56% and -9,171.60%.

Gross Margin	100.00%
Operating Margin	-9,994.56%
Pretax Margin	-9,171.60%
Profit Margin	-9,171.60%
EBITDA Margin	-8,702.89%
EBIT Margin	-9,171.60%
FCF Margin	-9,860.88%

Dividends & Yields

aTyr Pharma does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-57.72%
Shareholder Yield	-57.72%
Earnings Yield	-47.36%
FCF Yield	-50.92%

Analyst Forecast

Price Target	n/a
Price Target Difference	n/a
Analyst Consensus	n/a
Analyst Count	n/a
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

aTyr Pharma has an Altman Z-Score of -4.33 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-4.33
Piotroski F-Score	1